Rethinking Alzheimer’s clinical trials to include atypical forms of the disease
A paper published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association examines the limitations of current clinical trials in Alzh...
A paper published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association examines the limitations of current clinical trials in Alzh...
Menstruation may act as a cofactor that increases the severity of food allergic reactions in some women. Although this phenomenon remains poorly un...
Researchers from Clínic-IDIBAPS have participated in a study published in Nature Reviews Cancer that reviews how fat-associated liver diseases, kno...
Toilets and taps account for 71% of water consumption at the CEK, representing more than 1.9 million litres per year.
A study led by the Clínic‑IDIBAPS has shown that people with severe mental disorders present a higher risk of developing dementia at all ages and a...
IDIBAPS has welcomed two Nigerian students, Mohammed Umar and Muhammad Baba Goni, as part of a project aimed at promoting computational neuroscienc...
Barcelona hosts the Kick-Off meeting of the new European research project from IDIBAPS HypoGluTx, focused on preclinical therapy studies for rare d...
A multicentre study led by professionals from the Clínic-IDIBAPS shows that the immunomodulatory drug, abatacept, is more effective than convention...
Installed in the lobby of the Esther Koplowitz Center (C/ Rosselló, 149-153 Barcelona), the exhibition shows the 15 finalist photographs of the IX...
A molecular signature linking dysregulated lipid mediators and mitochondrial dysfunction offers new targets for therapeutic intervention and risk p...